SCHEMBL24951126

SCHEMBL24951126

CCOC(=O)c1ccc(F)c(NC(=O)c2cnc(Cl)nc2Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 7/20 0.50
▸ ATF1 P18846 5/20 0.50
▸ WDR5 P61964 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ RAB9A P51151 3/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ JUN P05412 2/20 0.44
▸ NFKB2 Q00653 2/20 0.44
▸ RELA Q04206 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TSHR P16473 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ SYK P43405 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30202837 1.00 NFKB1 (0.50) NFKB1ATF1WDR5KDM4EALDH1A1
SCHEMBL24951630 0.89 ALDH1A1 (0.50) NFKB1ATF1KDM4EALDH1A1RAB9A
SCHEMBL30202869 0.89 ALDH1A1 (0.50) NFKB1ATF1KDM4EALDH1A1RAB9A
SCHEMBL24951146 0.86 WDR5 (0.47) NFKB1ATF1WDR5KDM4EALDH1A1
SCHEMBL30202783 0.86 WDR5 (0.47) NFKB1ATF1WDR5KDM4EALDH1A1
SCHEMBL24952216 0.84 NFKB1 (0.50) NFKB1ATF1KDM4EALDH1A1RAB9A
SCHEMBL30202755 0.84 NFKB1 (0.50) NFKB1ATF1KDM4EALDH1A1RAB9A
SCHEMBL30202682 0.77 ALDH1A1 (0.46) NFKB1ATF1WDR5KDM4EALDH1A1
SCHEMBL24951831 0.77 ALDH1A1 (0.46) NFKB1ATF1WDR5KDM4EALDH1A1
SCHEMBL26962799 0.74 ALDH1A1 (0.76) KDM4EALDH1A1CYP1A2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023007009-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-02-02 — — WO disclosed
Send feedback